These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. Stam RW, Den Boer ML, Schneider P, de Boer J, Hagelstein J, Valsecchi MG, de Lorenzo P, Sallan SE, Brady HJ, Armstrong SA, Pieters R. Blood; 2010 Feb 04; 115(5):1018-25. PubMed ID: 19965632 [Abstract] [Full Text] [Related]
7. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M, Ballerini P, Cazzaniga G, Moreno T, Revilla C, Gut M, Valsecchi MG, Roberts I, Pieters R, De Lorenzo P, Varela I, Menendez P, Stam RW. Haematologica; 2019 Jun 04; 104(6):1176-1188. PubMed ID: 30679323 [Abstract] [Full Text] [Related]
9. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany RK, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J. Proc Natl Acad Sci U S A; 2012 Nov 20; 109(47):19397-402. PubMed ID: 23132946 [Abstract] [Full Text] [Related]
13. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. Nat Commun; 2012 Feb 21; 3():688. PubMed ID: 22353710 [Abstract] [Full Text] [Related]
15. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Stam RW, den Boer ML, Passier MM, Janka-Schaub GE, Sallan SE, Armstrong SA, Pieters R. Leukemia; 2006 Feb 21; 20(2):264-71. PubMed ID: 16357833 [Abstract] [Full Text] [Related]
16. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Orlovsky K, Kalinkovich A, Rozovskaia T, Shezen E, Itkin T, Alder H, Ozer HG, Carramusa L, Avigdor A, Volinia S, Buchberg A, Mazo A, Kollet O, Largman C, Croce CM, Nakamura T, Lapidot T, Canaani E. Proc Natl Acad Sci U S A; 2011 May 10; 108(19):7956-61. PubMed ID: 21518888 [Abstract] [Full Text] [Related]
17. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia. Shafik RE, Abd El Wahab N, Mokhtar MM, El Taweel MA, Ebeid E. Asian Pac J Cancer Prev; 2020 Nov 01; 21(11):3429-3434. PubMed ID: 33247705 [Abstract] [Full Text] [Related]
18. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW. Haematologica; 2013 Jun 01; 98(6):937-44. PubMed ID: 23403319 [Abstract] [Full Text] [Related]
19. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development. Schneider E, Staffas A, Röhner L, Krowiorz K, Heuser M, Döhner K, Bullinger L, Döhner H, Fogelstrand L, Rouhi A, Kuchenbauer F, Palmqvist L. Exp Hematol; 2016 Dec 01; 44(12):1166-1171. PubMed ID: 27619068 [Abstract] [Full Text] [Related]
20. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT. Blood; 2003 Jul 01; 102(1):262-8. PubMed ID: 12637319 [Abstract] [Full Text] [Related] Page: [Next] [New Search]